Ruth M. Lunn
- Cancer Research top 2%
- Carcinogens and Genotoxicity Assessment 14
- Otorhinolaryngology top 2%
- Molecular Biology top 5%
- DNA Repair Mechanisms 9
- Glutathione Transferases and Polymorphisms 6
- Epigenetics and DNA Methylation 5
- Oncology top 5%
-
- Oral health in cancer treatment 6
-
- Blood groups and transfusion 6
-
- Monoclonal and Polyclonal Antibodies Research 4
-
- Chemical Safety and Risk Management 4
- Co-authors
- Douglas A. BellDavid M. UmbachJack A. TaylorLing‐Ling HsiehClaudia ThompsonMichael P. WaalkesLorenzo TomatisJames Huff
- Partner nations
- United StatesCanadaFrance
In The Last Decade
Ruth M. Lunn
59 papers receiving 3.6k citations
Hit Papers
Peers
Comparison fields: 5 of 154
- Cancer Research 991
- Health, Toxicology and Mutagenesis 515
- Otorhinolaryngology 161
- Molecular Biology 2.1k
- Oncology 676
Countries citing papers authored by Ruth M. Lunn
This map shows the geographic impact of Ruth M. Lunn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruth M. Lunn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruth M. Lunn more than expected).
Fields of papers citing papers by Ruth M. Lunn
This network shows the impact of papers produced by Ruth M. Lunn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruth M. Lunn. The network helps show where Ruth M. Lunn may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ruth M. Lunn, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 2 | |
| 2 | 2023 | 12 | |
| 3 | 2021 | 7 | |
| 4 | 2019 | 48 | |
| 5 | 2018 | 38 | |
| 6 | 2010 | 98 | |
| 7 | 2007 | 335 | |
| 8 | 2004 | 84 | |
| 9 | 2002 | 62 | |
| 10 | 2002 | 102 | |
| 11 | Polymorphisms in the DNA repair gene XRCC1 and breast cancer. | 2001 | 131 |
| 12 | Polymorphisms In The DNA Repair Gene Xrcc1 And Breast Cancer | 2001 | 214 |
| 13 | 2000 | 6 | |
| 14 | 1998 | 57 | |
| 15 | 1998 | 7 | |
| 16 | 1996 | 72 | |
| 17 | 1996 | 38 | |
| 18 | 1995 | 6 | |
| 19 | 1990 | 6 | |
| 20 | 1988 | 22 |
About Ruth M. Lunn
Ruth M. Lunn is a scholar working on Chemical Health and Safety, Cancer Research and Otorhinolaryngology, having authored 59 papers that have together received 3.7k indexed citations. Recurring topics across this work include Carcinogens and Genotoxicity Assessment (14 papers), DNA Repair Mechanisms (9 papers), Oral health in cancer treatment (6 papers), Glutathione Transferases and Polymorphisms (6 papers), Blood groups and transfusion (6 papers), Epigenetics and DNA Methylation (5 papers), Monoclonal and Polyclonal Antibodies Research (4 papers) and Chemical Safety and Risk Management (4 papers). The work is most often cited by research in Cancer Research (991 citations), Health, Toxicology and Mutagenesis (515 citations) and Otorhinolaryngology (161 citations). Ruth M. Lunn has collaborated with scholars based in United States, Canada and France. Frequent co-authors include Douglas A. Bell, David M. Umbach, Jack A. Taylor, Ling‐Ling Hsieh, Claudia Thompson, Michael P. Waalkes, Lorenzo Tomatis, James Huff, Peter F. Infante and Joel B. Epstein. Their work appears in journals such as Blood, The Journal of Immunology and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.